Scoring system for mortality prediction of in-hospital COVID-19 patients in resource-limited settings: a single center cohort study during Delta and Omicron waves
Prognostic coring of COVID-19 patients
,
Abstract
Objective: Coronavirus Disease 2019 (COVID-19)-related mortality includes several risk variables that are country-specific in nature. The development of a scoring system is necessary regarding the appearance of novel virus variants. The objective of this research is to develop a prognostic score for COVID-19 patients in resource-constrained settings. Methods: This study used a retrospective and prospective cohort design to identify variables that influence COVID-19 patients' in-hospital mortality. The receiver operating characteristic (ROC) curve analysis was utilized to determine the laboratory variables cut-off. Cox regression analysis was undertaken to determine the exact variables influencing the survival of COVID-19 patients. A scoring system was created using the best model based on the Hosmer-Lemeshow test (calibration) and the area under the curve (AUC) (discrimination ability). Results: Based on calibration and discrimination testing, model 2 (immune disorders, unconsciousness, cerebrovascular disease, onset, and oxygen saturation) was rated as the most advantageous model. Model 2 (without age adjustment) had a superior AUC than model 2A (with age). Cut-off was determined at 2, and calculated for onset ≥7 days (AUC=0.816, 95% CI: 0.742,0.890) and <7 days (AUC=0.850, 95% CI: 0.784,0.916). There was no difference in scoring system utilization for subjects recruited during Delta or Omicron waves (P=0.527). Conclusion: The model (cut-off value ≥2) which incorporated age ≥65 years, immune disorders, decreased consciousness, increased respiratory rate, and oxygen saturation <95% is the best model in our study to predict COVID-19 patient mortality.
Jain N, Hung I-C, Kimura H, Goh YL, Jau W, Huynh KLA, et al. The global response: how cities and provinces around the globe tackled covid-19 outbreaks in 2021. Lancet Reg Heal Asia. 2022;4:100031.
Farahat RA, Abdelaal A, Umar TP, El-Sakka AA, Benmelouka AY, Albakri K, et al. The emergence of SARS-CoV-2 Omicron subvariants: current situation and future trends. Le Infez Med. 2022;30(4):480-94.
COVID-19 Excess Mortality Collaborators. Estimating excess mortality due to the COVID-19 pandemic: a systematic analysis of COVID-19-related mortality, 2020-21. Lancet. 2022;399(10334):1513–36.
Jo S, Nam H, Kang H, Cho S. Associations of symptom combinations with in-hospital mortality of coronavirus disease-2019 patients using South Korean national data. PLoS One. 2022;17(8):e0273654.
Surendra H, Paramita D, Arista NN, Putri AI, Siregar AA, Puspaningrum E, et al. Geographical variations and district-level factors associated with COVID-19 mortality in Indonesia: a nationwide ecological study. BMC Public Health. 2023;23(1):103.
Widiawaty MA, Lam KC, Dede M, Asnawi NH. Spatial differentiation and determinants of COVID-19 in Indonesia. BMC Public Health. 2022;22(1):1030.
Hilda F, Liana P, Nurtjahyo A, Hudari H, Sari NP, Umar TP, et al. D-dimer as a sensitive biomarker of survival rate in patients with COVID-19. Eurasian J Med. 2022;54(3):219–24.
Shang Y, Liu T, Wei Y, Li J, Shao L, Liu M, et al. Scoring systems for predicting mortality for severe patients with COVID-19. EClinicalMedicine. 2020;24:100426.
Knight SR, Ho A, Pius R, Buchan I, Carson G, Drake TM, et al. Risk stratification of patients admitted to hospital with covid-19 using the ISARIC WHO clinical characterisation protocol: development and validation of the 4C mortality score. BMJ. 2020;370:m3339.
Lee D-G. Prognosis score system to predict survival for COVID-19 cases: a Korean nationwide cohort study. J Med Internet Res. 2021;23(2):e26257.
Saldi SRF, Safitri ED, Setiati S, Ranakusuma RW, Marsigit J, Azwar MK, et al. Prognostic scoring system for mortality of hospitalized COVID-19 patients in resource-limited settings: a multicenter study from COVID-19 referral hospitals. Acta Med Indones. 2021;53(4):407–15.
Farahat RA, Baklola M, Umar TP. Omicron B.1.1.529 subvariant: brief evidence and future prospects. Ann Med Surg. 2022;83:104808.
Sun C, Xie C, Bu G-L, Zhong L-Y, Zeng M-S. Molecular characteristics, immune evasion, and impact of SARS-CoV-2 variants. Signal Transduct Target Ther. 2022;7(1):202.
Dessie ZG, Zewotir T. Mortality-related risk factors of COVID-19: a systematic review and meta-analysis of 42 studies and 423,117 patients. BMC Infect Dis. 2021;21(1):855.
Gao Y, Chen Y, Liu M, Niu M, Song Z, Yan M, et al. Nervous system diseases are associated with the severity and mortality of patients with COVID-19: a systematic review and meta-analysis. Epidemiol Infect. 2021;149:e66.
Di Gennaro F, Pizzol D, Marotta C, Antunes M, Racalbuto V, Veronese N, et al. Coronavirus diseases (COVID-19) current status and future perspectives: a narrative review. Int J Environ Res Public Health. 2020;17(8):2690.
Chatterjee NA, Jensen PN, Harris AW, Nguyen DD, Huang HD, Cheng RK, et al. Admission respiratory status predicts mortality in COVID‐19. Influenza Other Respi Viruses. 2021;15(5):569-72.
Xiong W, Lu L, Zhang B, Luo J, Li W, He L, et al. Association of consciousness impairment and mortality in people with COVID-19. Acta Neurol Scand. 2021;144(3):251-9.
Ikram AS, Pillay S. Admission vital signs as predictors of COVID-19 mortality: a retrospective cross-sectional study. BMC Emerg Med. 2022;22(1):68.
Tadesse Z, Bekele Bayissa A, Diriba T, Chernet N, Tsegaye S, Tsega M. Neutrophil-to-lymphocyte ratio and cut-off values as predictor of severity and mortality in COVID-19 patients in millennium COVID-19 care center, Addis Ababa, Ethiopia. Int J Gen Med. 2022;2022:6739-55.
Faustine I, Malik A, Andrajati R, Wanandi SI. Clinical characteristics and severity profile of COVID-19 patient with hypertension in Palu, Central Sulawesi. Indones J Pharmacy/Majalah Farm Indones. 2021;32(4):563-72.
Pambudi IGPB, Suryana IK, Rai IBN, Kusumawardani IAJD, Candrawati NW, Sajinadiyasa IGK, et al. High neutrophil to lymphocyte ratio, C-reactive protein, procalcitonin and D-dimer as risk factors for severe COVID-19. Medico-Legal Updat. 2022;22(1):41-6.
Ahmed S, Ahmed ZA, Siddiqui I, Rashid NH, Mansoor M, Jafri L. Evaluation of serum ferritin for prediction of severity and mortality in COVID-19-a cross sectional study. Ann Med Surg. 2021;63:102163.
Ak R, Kurt E, Bahadirli S. Comparison of 2 risk prediction models specific for COVID-19: the Brescia-COVID respiratory severity scale versus the quick COVID-19 severity index. Disaster Med Public Health Prep. 2021;15(4):e46-50.
Webb BJ, Levin NM, Grisel N, Brown SM, Peltan ID, Spivak ES, et al. Simple scoring tool to estimate risk of hospitalization and mortality in ambulatory and emergency department patients with COVID-19. PLoS One. 2022;17(3):e0261508.
Hashim MJ, Alsuwaidi AR, Khan G. Population risk factors for COVID-19 mortality in 93 countries. J Epidemiol Glob Health. 2020;10(3):204-8.
Bouzid D, Visseaux B, Kassasseya C, Daoud A, Fémy F, Hermand C, et al. Comparison of patients infected with Delta versus Omicron COVID-19 variants presenting to Paris emergency departments : a retrospective cohort study. Ann Intern Med. 2022;175(6):831-7.
Surendra H, Elyazar IRF, Djaafara BA, Ekawati LL, Saraswati K, Adrian V, et al. Clinical characteristics and mortality associated with COVID-19 in Jakarta, Indonesia: a hospital-based retrospective cohort study. Lancet Reg Heal – West Pacific. 2021;9:100108.
Marcolino MS, Pires MC, Ramos LEF, Silva RT, Oliveira LM, Carvalho RLR, et al. ABC2-SPH risk score for in-hospital mortality in COVID-19 patients: development, external validation and comparison with other available scores. Int J Infect Dis. 2021;110:281-308.
Andrade C. Internal, external, and ecological validity in research design, conduct, and evaluation. Indian J Psychol Med. 2018;40(5):498-9.
Delgado-Rodríguez M, Llorca J. Bias. J Epidemiol Community Health. 2004;58(8):635-41.
Sirohiya P, Elavarasi A, Sagiraju HKR, Baruah M, Gupta N, Garg RK, et al. Silent hypoxia in Coronavirus disease-2019: is it more dangerous? -A retrospective cohort study. Lung India. 2022;39(3):247-53.
| Files | ||
| Issue | Vol 7 No 4 (2023): Autumn (October) | |
| Section | Original article | |
| DOI | 10.18502/fem.v7i4.14475 | |
| Keywords | ||
| COVID-19 Prognostic Scoring System Survival | ||
| Rights and permissions | |
|
This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License. |
